NIH-funded research R01 grant

Exploring how gut bacteria affect brain health in Alzheimer's disease

Official title: Understanding the Microbiome-gut-brain axisn Alzheimer disease and its Role in Cognitive Decline

Funded at Univ of Massachusetts Med Sch Worcester · NIH-10875702 · Data updated 2026-11-12

This study is looking at how the bacteria in our gut might affect memory and thinking skills in older adults with Alzheimer's, and it's inviting seniors from nursing homes and community centers to help by sharing stool samples so researchers can learn more about this connection.

More Alzheimer Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startSeptember 15, 2020
Project endAugust 31, 2025
Funding year2024
Award (this year)$728,896
NIH project number4R01AG067483-02
Project IDNIH-10875702 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include elderly individuals diagnosed with Alzheimer's disease or those experiencing cognitive decline.

Less likely to help

Patients with non-neurodegenerative cognitive impairments or those not diagnosed with Alzheimer's disease may not benefit from this research.

What this research studies

This research investigates the connection between the gut microbiome and Alzheimer's disease, focusing on how changes in gut bacteria may influence cognitive decline. By enrolling elderly participants from nursing homes and community centers, the study aims to analyze the composition of gut bacteria and their metabolic products. Researchers will collect stool samples to assess inflammation levels and their relationship to cognitive health. The goal is to better understand how gut health impacts brain function in Alzheimer's patients.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cognitive decline in Alzheimer's disease through microbiome modulation.

How similar studies have gone: Previous research has shown promising results in understanding the microbiome's role in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Haran, John Patrick — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Haran, John Patrick

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.